...
首页> 外文期刊>Pharmaceuticals >Development and Characterization of Chitosan Microparticles-in-Films for Buccal Delivery of Bioactive Peptides
【24h】

Development and Characterization of Chitosan Microparticles-in-Films for Buccal Delivery of Bioactive Peptides

机译:用于生物活性肽经颊部递送的壳聚糖膜中微粒的开发和表征

获取原文

摘要

Nowadays, bioactive peptides are used for therapeutic applications and the selection of a carrier to deliver them is very important to increase the efficiency, absorption, release, bioavailability and consumer acceptance. The aim of this study was to develop and characterize chitosan-based films loaded with chitosan microparticles containing a bioactive peptide (sequence: KGYGGVSLPEW) with antihypertensive properties. Films were prepared by the solvent casting method, while the microparticles were prepared by ionic gelation. The final optimized chitosan microparticles exhibited a mean diameter of 2.5 μm, a polydispersity index of 0.46, a zeta potential of +61 mV and a peptide association efficiency of 76%. Chitosan films were optimized achieving the final formulation of 0.79% ( w / v ) of chitosan, 6.74% ( w / v ) of sorbitol and 0.82% ( w / v ) of citric acid. These thin (±0.100 mm) and transparent films demonstrated good performance in terms of mechanical and biological properties. The oral films developed were flexible, elastic, easy to handle and exhibited rapid disintegration (30 s) and an erosion behavior of 20% when they came into contact with saliva solution. The cell viability (75–99%) was proved by methylthiazolydiphenyl-tetrazolium bromide (MTT) assay with TR146 cells. The chitosan mucoadhesive films loaded with peptide–chitosan microparticles resulted in an innovative approach to perform administration across the buccal mucosa, because these films present a larger surface area, leading to the rapid disintegration and release of the antihypertensive peptide under controlled conditions in the buccal cavity, thus promoting bioavailability.
机译:如今,生物活性肽被用于治疗应用,选择载体来递送它们对于提高效率,吸收,释放,生物利用度和消费者接受度非常重要。这项研究的目的是开发和表征基于壳聚糖的薄膜,该薄膜负载了含有具有降压特性的生物活性肽(序列:KGYGGVSLPEW)的壳聚糖微粒。通过溶剂流延法制备膜,而通过离子凝胶化制备微粒。最终优化的壳聚糖微粒的平均直径为2.5μm,多分散指数为0.46,ζ电位为+61 mV,肽缔合效率为76%。对壳聚糖膜进行了优化,最终配方为0.79%(w / v)的壳聚糖,6.74%(w / v)的山梨糖醇和0.82%(w / v)的柠檬酸。这些薄(±0.100 mm)的透明薄膜在机械和生物学特性方面表现出良好的性能。所形成的口腔膜具有柔韧性,弹性,易处理性,与唾液接触时表现出快速崩解(30 s)和20%的腐蚀行为。用TR146细胞的甲基噻唑基二苯基溴化四氮唑(MTT)分析证明了细胞活力(75–99%)。载有肽-壳聚糖微粒的壳聚糖粘膜粘附膜产生了一种创新的方法,可在整个颊粘膜上进行给药,因为这些膜具有较大的表面积,从而导致在受控条件下在颊腔中降压肽的快速崩解和释放,从而提高生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号